Another way drug companies are responding to the GLP-1 shortage is by bringing new therapeutic options to the market
Foods containing potassium (such as bananas, oranges, potatoes, and leafy greens) are part of a balanced diet, but avoid making significant dietary changes or taking supplements that increase potassium intake without medical advice, particularly if you have kidney disease or take medications such as ACE inhibitors, ARBs, or potassium-sparing diuretics
This process involves submitting necessary documents to your insurer and coordinating the approval, reducing the potential for out-of-pocket expenses
So that tension between the Fed's delay to get ahead of the curve and the market's need for speed to get there sooner and more deliberately is where we think that, you know, we have to wait for that to occur to get the full rotation to the lower quality, kind of really cyclical parts of the market
Balette says "weight-loss medications," he does not mean only GLP-1s
Existing literature indicates that GLP-1R agonists also suppress reinstatement for cocaine (56), nicotine (57), and opioids (58), further supporting a potential effect on relapse-like behaviors
:quality(85):extract_cover()/2024/09/19/768/n/49351082/tmp_kfDUx8_8844982382f654b3_SHOT-11-GLP-72-0.JPEG)
